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                                                    ABSTRACT 
BACKGROUND 
     The antibiotic resistance among Proteus infections occur due to the frequent and 
inappropriate use of antibiotics . The most common resistance mechanism related   with 
β-lactams is the production of β-Lactamases. Among the new ESBL families CTX -M is 
emerging as the commonest gene. Plasmids encoding for ESBL enzymes also carry co-
resistance genes for other non β–lactam antibiotics, limiting the number of drugs against 
this bacteria. 
MATERIALS AND METHODS: 
In Tirunelveli Medical College, a total of 100 Proteus isolates were screened for 
ESBL production with 3rd generation Cephalosporins and the resistant isolates were 
confirmed with phenotypic tests Combined disc test, Double disc synergy test and ESBL 
E test. Then Real-Time PCR was done to identify the presence of blaCTX-M gene .The 
antimicrobial susceptibility patterns of Proteus isolates and the risk factors for ESBL 
production among those isolates were analysed. 
RESULTS : 
      Among the 53% of ESBL producers among Proteus species,90.5% were found to have 
blaCTX –M gene by PCR .98% of ESBL producing Proteus were sensitive to 
Piperacillin/Tazobactum and Imipenem .  The CDT is the simple, cost effective method in 
the detection of the ESBL. Prior exposure to Cephalosporins and Catheterisation among 
them were found statistically significant among these patients. 
CONCLUSION: 
            Treatment failure, morbidity and mortality are more likely to occur in 
patients infected with ESBLs producing Proteus thereby rising the medical and 
surgical care costs. so the various resistance genes needs for a regular review of its 
sensitivity pattern . 
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